Evidence map›Paper›PMID 33225208›Full record

ArticleJNCI cancer spectrum2020

Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial.

Ting Bao, Iris Zhi, Raymond Baser, Madeline Hooper, Connie Chen, Lauren Piulson, Qing S Li, Mary Lou Galantino, Victoria Blinder, Mark Robson and 3 more

Open access · goldAbstract read
In one paragraph

Article in JNCI cancer spectrum, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 7 pooled it
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 7 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. BeyondFrontiers in pain research (Lausanne, Switzerland) · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ting BaoMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4437-2597
Iris ZhiMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Raymond BaserMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-1644-4090
Madeline HooperMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Connie ChenMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-5384-4707
Lauren PiulsonMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Qing S LiMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Mary Lou GalantinoStockton University, Galloway, NJ, USA.ORCID 0000-0002-3020-8895
Victoria BlinderMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Mark RobsonMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-3109-1692
Andrew SeidmanMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Katherine S PanageasMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Jun J MaoMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-9229-0380
Memorial Sloan Kettering Cancer Center · USStockton University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundChemotherapy-induced peripheral neuropathy (CIPN) is a common, debilitating side effect that worsens quality of life and increases the risk of falls in cancer survivors. Evidence of yoga's safety and efficacy in treating CIPN is lacking.

methodsIn a randomized controlled study, we assigned breast and gynecological cancer survivors with persistent moderate-to-severe CIPN pain, numbness, or tingling with a score of 4 or greater (0-10 numeric rating scale [NRS]) for at least 3 months after chemotherapy to 8 weeks of usual care or yoga focused on breathwork and musculoskeletal conditioning. Primary endpoint was treatment arm differences for NRS, and secondary endpoints were Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx), and Functional Reach Test after week 8. We tested treatment arm differences for each outcome measure using linear mixed models with treatment-by-time interactions. All statistical tests were two-sided.

resultsWe randomly assigned 41 participants into yoga (n = 21) or usual care (n = 20). At week 8, mean NRS pain decreased by 1.95 points (95% confidence interval [CI] = -3.20 to -0.70) in yoga vs 0.65 (95% CI = -1.81 to 0.51) in usual care (

conclusionAmong breast and gynecological cancer survivors with moderate-to-severe CIPN, yoga was safe and showed promising efficacy in improving CIPN symptoms.

Identifiers

PMID33225208
PMCPMC7666827
OpenAlexW3034133610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.